Modelling allopurinol-induced severe adverse cutaneous reactions

Rebecca Grainger; Lisa K Stamp

doi:10.1016/S2665-9913(25)00220-6

Back

Letter/Communication

Modelling allopurinol-induced severe adverse cutaneous reactions

Rebecca Grainger and Lisa K Stamp

The Lancet. Rheumatology

04/09/2025

DOI: https://doi.org/10.1016/S2665-9913(25)00220-6

Handle:

https://hdl.handle.net/10523/47958

Abstract

Letter

Comment on Cipolletta et al. (2025). Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data. The Lancet. Rheumatology, https://doi.org/10.1016/S2665-9913(25)00165-1.

Metrics

5 Record Views

See more details

Details

Record Identifier: 9926769144401891
Title: Modelling allopurinol-induced severe adverse cutaneous reactions
Creators: Rebecca Grainger
Lisa K Stamp
Publication Details: The Lancet. Rheumatology
Academic Unit: Medicine (UOC); Medicine (UOW)
Publisher: Elsevier
Date published ; e-published: 04/09/2025
Comment: The published version is not available in full-text in OUR Archive. Where available, a link to the published version is provided (check the DOI and/or the Files and links section). The full-text item may be open access on the publisher's website. An earlier version of the work (such as authors' accepted manuscript following peer-review or unreviewed preprint/author's original version) may be available in the Files and links section of this record. Alternatively, readers may have subscription access to the full-text from the publisher.
Language: English
Resource Type ; Subtype: Letter/Communication

Modelling allopurinol-induced severe adverse cutaneous reactions

Abstract

Related links

Metrics

Details